Institutional Registry of Thromboembolic Disease (IRTD)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01372514|
Recruitment Status : Recruiting
First Posted : June 14, 2011
Last Update Posted : December 17, 2015
The purpose of this study is to create an institutional registry of Thromboembolic disease through a prospective survey based on epidemiological data, risk factors, diagnosis, prognosis, treatment, monitoring and survival.
The main goal is to describe the occurrence of thromboembolic disease and the characteristics of clinical presentation, evolution and predisposing factors of these episodes in the population of the Hospital Italiano de Buenos Aires.
|Condition or disease|
|Thromboembolism Venous Thromboembolism Pulmonary Embolism|
Deep Vein Thrombosis (DVT) and pulmonary thromboembolism (PTE) are the most common clinical manifestations of thromboembolic disease (TD). The PTE is one of the most important preventable causes of death in hospitalized patients, with a mortality up to 17% in a 3 month period. During the past 20 years important changes have been made in terms of clinical awareness, diagnostic tools and treatment.
No data has been found in our country which shows the TD population incidence. According to WHO, the sex-specific mortality rate associated to TD in Argentina in the year 2001 (including DVT and PE coded by ICD10), estimated by epidemiological death records was 0.2 / 100,000 for men and 0, 5 / 100000 for women (based on 37 and 87 cases respectively). This seems to represent a clear report deficiency.
Registries are systematic surveys which are found in a database. They function as monitoring lists and allow epidemiological evaluations of the affected patients. Several methods can be found to diagnose thromboembolic disease. These include OPTIMEV: Interrogatoire Optimisation de l'évaluation du risque dans l'Maladie ThromboEmbolique of Veineuse (its aim is to include about 10000 cases of suspected DT); MAPPET: Management Strategy and Prognosis of Pulmonary Embolism Registry (its goal is to include 1001 consecutive patients with PE), ICOPER: International Cooperative Pulmonary Embolism Registry (to include 2454 consecutive patients with PE), DVT FREE (including TVP 5451),RIETE: Computerized Patient Record venous thromboembolism in Spain (to register patients with DVT or PE).
No published records have been found regarding the approach used for diagnosis and treatment of suspected PTE patients in our country. Moreover, no publications on systematic epidemiological data (risk factors, assessment and follow-up survival, complications and recurrences)were found.
The registry of suspected TD cases will allow us to distinguish the disease characteristics in our community, the most used diagnostic strategies, the results and the pathology evolution in time.
The Hospital Italiano counts with computerized clinical records which provide incidence, morbidity and mortality data.
It is our belief that this registry will allow us to design studies to improve and standardize the most used diagnostic strategies.
|Study Type :||Observational|
|Estimated Enrollment :||4500 participants|
|Official Title:||Institutional Registry of Thromboembolic Disease|
|Study Start Date :||August 2006|
|Estimated Primary Completion Date :||January 2020|
|Estimated Study Completion Date :||January 2020|
suspected thromboembolic disease
Patients with thromboembolic disease according to diagnostic tests (MDTC with angiography, scintigraphy V/Q, dimer d, ecografia doppler, etc. ) required by the physician.
- Incidence [ Time Frame: 4 years ]
- evaluate new hypothesis [ Time Frame: yearly ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01372514
|Contact: Diego H Giunta, MD||005411-49590200 ext email@example.com|
|Contact: Lourdes M Posadas-Martínez, MD||005411-49590200 ext firstname.lastname@example.org|
|Buenos Aires, Argentina|
|Contact: Diego H Giunta, MD 005411-49590200 ext 4419 email@example.com|
|Contact: Cristina M Elizondo, MD 005411-49590200 ext 4419 firstname.lastname@example.org|
|Principal Investigator: Diego H Giunta, MD|
|Sub-Investigator: Lourdes Posadas-MArtinez, MD|
|Principal Investigator:||Diego H Giunta, MD||Internal Medicine Clinical research Area Coordinator|
|Study Director:||Fernan Gonzales Bernaldo de Quirós, MD||Internal Medicine Clinical Research Area Chief|
|Study Chair:||Fernando Vazquez, MD||Internal Medicine Staff|
|Study Chair:||Lourdes Posadas-MArtínez, MD||Internal Medicine Clinical research Area , HIBA|